Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Uncover which credit card gives the best points for your spending habits. Find the right card to maximize your rewards.
19,343 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
With $1,000 to invest, you’re at a crossroads: bet on XRP’s institutional plumbing or Zcash’s privacy-forward store o...
Investors are weighing the upside of autonomous trucking against cost, timing, and risk. This article breaks down the...
The crypto market has questions about XRP at sub-$1.50 levels. This guide weighs the risks and potential rewards, off...
A surge in AI-focused crypto has investors weighing a $500 bet. This article breaks down how the technology works, th...
Two popular consumer staples ETFs—FSTA and FTXG—offer different routes to defense in a volatile market. This guide br...
Chewy has faced a rough year, with shares falling and growth challenges ahead. Yet, a closer look under the hood show...
Archer Aviation trades under $7 as it pursues a future of urban air taxis. This deep-dive breaks down milestones, ris...
SoundHound AI trades in a fast-moving AI landscape with big growth potential and meaningful risks. This piece breaks ...
Stocks closed higher for an eighth straight week as earnings buoy sentiment, even as a key consumer confidence gauge ...
AI-driven capex sustains a two-horse race in semiconductors. This piece weighs which is the better semi stock to buy ...
Bitcoin is in a slow bleed phase as distribution-driven selling deepens, with May’s rally fading and spot ETF flows t...